Pulmonary valve prosthesis percutaneously delivered
PMA Number: P200046 · 2021-12-16
Device Summary
Frequently Asked Questions
What is Pulmonary valve prosthesis percutaneously delivered?
Pulmonary valve prosthesis percutaneously delivered is a medical device that received FDA Premarket Approval (PMA) on 2021-12-16. It is manufactured by Medtronic, Inc.. The PMA number is P200046.
When did Pulmonary valve prosthesis percutaneously delivered receive FDA PMA approval?
Pulmonary valve prosthesis percutaneously delivered received FDA PMA approval on 2021-12-16, under approval number P200046.
What company makes Pulmonary valve prosthesis percutaneously delivered?
Pulmonary valve prosthesis percutaneously delivered is manufactured by Medtronic, Inc..
What is the difference between PMA and 510(k)?
PMA (Premarket Approval) is the FDA process for evaluating Class III medical devices. Unlike 510(k) clearance, which demonstrates substantial equivalence to a predicate device, PMA requires the manufacturer to provide clinical data proving safety and effectiveness. PMA is the most stringent type of device marketing application required by the FDA.
What is the FDA product code for Pulmonary valve prosthesis percutaneously delivered?
The FDA product code for Pulmonary valve prosthesis percutaneously delivered is NPV.
Related Clinical Trials
Other Devices by Medtronic, Inc.
Related Devices (Code: NPV)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.